188 related articles for article (PubMed ID: 12021356)
1. Three regions of the pRB pocket domain affect its inactivation by human papillomavirus E7 proteins.
Dick FA; Dyson NJ
J Virol; 2002 Jun; 76(12):6224-34. PubMed ID: 12021356
[TBL] [Abstract][Full Text] [Related]
2. Mutagenesis of the pRB pocket reveals that cell cycle arrest functions are separable from binding to viral oncoproteins.
Dick FA; Sailhamer E; Dyson NJ
Mol Cell Biol; 2000 May; 20(10):3715-27. PubMed ID: 10779361
[TBL] [Abstract][Full Text] [Related]
3. Molecular determinants for the complex formation between the retinoblastoma protein and LXCXE sequences.
Singh M; Krajewski M; Mikolajka A; Holak TA
J Biol Chem; 2005 Nov; 280(45):37868-76. PubMed ID: 16118215
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel retinoblastoma gene product binding site on human papillomavirus type 16 E7 protein.
Patrick DR; Oliff A; Heimbrook DC
J Biol Chem; 1994 Mar; 269(9):6842-50. PubMed ID: 8120046
[TBL] [Abstract][Full Text] [Related]
5. Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor.
Ledl A; Schmidt D; Müller S
Oncogene; 2005 May; 24(23):3810-8. PubMed ID: 15806172
[TBL] [Abstract][Full Text] [Related]
6. The canine papillomavirus and gamma HPV E7 proteins use an alternative domain to bind and destabilize the retinoblastoma protein.
Wang J; Zhou D; Prabhu A; Schlegel R; Yuan H
PLoS Pathog; 2010 Sep; 6(9):e1001089. PubMed ID: 20824099
[TBL] [Abstract][Full Text] [Related]
7. Determination of the binding affinity of different human papillomavirus E7 proteins for the tumour suppressor pRb by a plate-binding assay.
Dong WL; Caldeira S; Sehr P; Pawlita M; Tommasino M
J Virol Methods; 2001 Oct; 98(1):91-8. PubMed ID: 11543887
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus type 16 E7 protein inhibits DNA binding by the retinoblastoma gene product.
Stirdivant SM; Huber HE; Patrick DR; Defeo-Jones D; McAvoy EM; Garsky VM; Oliff A; Heimbrook DC
Mol Cell Biol; 1992 May; 12(5):1905-14. PubMed ID: 1314947
[TBL] [Abstract][Full Text] [Related]
9. Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein.
Huang PS; Patrick DR; Edwards G; Goodhart PJ; Huber HE; Miles L; Garsky VM; Oliff A; Heimbrook DC
Mol Cell Biol; 1993 Feb; 13(2):953-60. PubMed ID: 7678696
[TBL] [Abstract][Full Text] [Related]
10. Retinoblastoma protein binding properties are dependent on 4 cysteine residues in the protein binding pocket.
Stirdivant SM; Ahern JD; Oliff A; Heimbrook DC
J Biol Chem; 1992 Jul; 267(21):14846-51. PubMed ID: 1321820
[TBL] [Abstract][Full Text] [Related]
11. The high-risk HPV16 E7 oncoprotein mediates interaction between the transcriptional coactivator CBP and the retinoblastoma protein pRb.
Jansma AL; Martinez-Yamout MA; Liao R; Sun P; Dyson HJ; Wright PE
J Mol Biol; 2014 Dec; 426(24):4030-4048. PubMed ID: 25451029
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the binding of the human papillomavirus type 16 and cottontail rabbit papillomavirus E7 proteins to the retinoblastoma gene product.
Haskell KM; Vuocolo GA; Defeo-Jones D; Jones RE; Ivey-Hoyle M
J Gen Virol; 1993 Jan; 74 ( Pt 1)():115-9. PubMed ID: 8380832
[TBL] [Abstract][Full Text] [Related]
13. Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes.
Helt AM; Galloway DA
J Virol; 2001 Aug; 75(15):6737-47. PubMed ID: 11435552
[TBL] [Abstract][Full Text] [Related]
14. Role of LXCXE motif-dependent interactions in the activity of the retinoblastoma protein.
Chan HM; Smith L; La Thangue NB
Oncogene; 2001 Sep; 20(43):6152-63. PubMed ID: 11593423
[TBL] [Abstract][Full Text] [Related]
15. Induction of pRb degradation by the human papillomavirus type 16 E7 protein is essential to efficiently overcome p16INK4a-imposed G1 cell cycle Arrest.
Giarrè M; Caldeira S; Malanchi I; Ciccolini F; Leão MJ; Tommasino M
J Virol; 2001 May; 75(10):4705-12. PubMed ID: 11312342
[TBL] [Abstract][Full Text] [Related]
16. Structural basis for recognition of the tumor suppressor protein PTPN14 by the oncoprotein E7 of human papillomavirus.
Yun HY; Kim MW; Lee HS; Kim W; Shin JH; Kim H; Shin HC; Park H; Oh BH; Kim WK; Bae KH; Lee SC; Lee EW; Ku B; Kim SJ
PLoS Biol; 2019 Jul; 17(7):e3000367. PubMed ID: 31323018
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of small molecule antagonists of pRb inactivation by viral oncoproteins.
Fera D; Schultz DC; Hodawadekar S; Reichman M; Donover PS; Melvin J; Troutman S; Kissil JL; Huryn DM; Marmorstein R
Chem Biol; 2012 Apr; 19(4):518-28. PubMed ID: 22520758
[TBL] [Abstract][Full Text] [Related]
18. Structure of the human Papillomavirus E7 oncoprotein and its mechanism for inactivation of the retinoblastoma tumor suppressor.
Liu X; Clements A; Zhao K; Marmorstein R
J Biol Chem; 2006 Jan; 281(1):578-86. PubMed ID: 16249186
[TBL] [Abstract][Full Text] [Related]
19. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions.
von Knebel Doeberitz M; Rittmüller C; Aengeneyndt F; Jansen-Dürr P; Spitkovsky D
J Virol; 1994 May; 68(5):2811-21. PubMed ID: 8151752
[TBL] [Abstract][Full Text] [Related]
20. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product.
Chellappan S; Kraus VB; Kroger B; Munger K; Howley PM; Phelps WC; Nevins JR
Proc Natl Acad Sci U S A; 1992 May; 89(10):4549-53. PubMed ID: 1316611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]